Jan-Olav Henck, PhD,
chief scientific officer
Jan-Olav Henck, PhD, chief scientific officer at Aptuit, discusses strategies and considerations in polymorph screening with Patricia Van Arnum, senior editor of Pharmaceutical Technology (Posted November 2011).
The addition of a new manufacturing line at Lonza’s Portsmouth, NH site enables Alexion to add dedicated product supply for 10 years.
Evans Analytical Group expands into the pharmaceutical/biopharmaceutical industry with acquisition of ABC Laboratories.
The broader aim of FDA's metrics initiative is to encourage quality manufacturing operations that will help avoid drug shortages.
FDA’s quality metrics draft guidance details the types of data the agency plans to request and the quality metrics it plans to calculate.
EMA’s revised guideline on the implementation of accelerated assessment is open for public consultation.
Ingredients Insider Cynthia ChallenerLack of Expertise Hinders Adoption of Continuous API Synthesis